CA2291471A1 — Lowering blood levels of lipoprotein(a)
Assigned to Pfizer Products Inc · Expires 2000-06-04 · 26y expired
What this patent protects
The invention relates to methods of lowering blood levels of lipoprotein(a) in a mammal which comprises administering to a mammal in need thereof a lipoprotein(a) blood level-lowering amount of an apolipoprotein B secretion/microsomal triglyceride transfer protein inhibitor.
USPTO Abstract
The invention relates to methods of lowering blood levels of lipoprotein(a) in a mammal which comprises administering to a mammal in need thereof a lipoprotein(a) blood level-lowering amount of an apolipoprotein B secretion/microsomal triglyceride transfer protein inhibitor.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.